rethinkTHC Search
Menu
Study breakdown

Cannabis modulates six major brain neurotransmitter systems, with profound implications for mental health

ReviewModerate evidence
The takeaway

A review of preclinical and clinical evidence found cannabinoid receptors modulate dopamine, serotonin, noradrenaline, GABA, glutamate, and opioid systems, explaining the broad range of cannabis effects from pain relief to psychosis risk.

Neuropharmacologists, psychiatrists, and researchers studying cannabinoid mechanisms.

6 neurotransmitter systems affected

What the researchers found

CB1 and CB2 receptors interact with six major neurotransmitter systems: dopamine, serotonin, noradrenaline, GABA, glutamate, and opioids. Acute and chronic cannabis exposure produces distinct pharmacological alterations across these systems. The neuromodulatory role of the endocannabinoid system explains why cannabis affects such a wide range of mental health domains.

Why it matters

Understanding how cannabinoids interact with established neurotransmitter systems is essential for predicting both therapeutic effects and risks. The breadth of these interactions explains why cannabis has such diverse and sometimes contradictory effects.

The numbers in context

6 major neurotransmitter systems modulated: dopamine, serotonin, noradrenaline, GABA, glutamate, opioids. Both CB1 and CB2 receptors involved. Acute and chronic effects differ.

How the study worked

Review summarizing preclinical and clinical data on cannabinoid receptor interactions with major central neurotransmitter systems, covering both acute and chronic exposure effects.

What this study cannot tell us

Much of the evidence is preclinical. Translating neurotransmitter-level findings to clinical outcomes is complex. The review covers breadth at the expense of depth for individual neurotransmitter interactions.

How to read the evidence

Rated moderate because the review synthesizes substantial preclinical and clinical evidence, though individual interactions are at different evidence levels.

When this study was published

Published in 2019.

The bigger picture

Cannabis is not a single-target drug. Its modulatory effects on virtually every major neurotransmitter system explain both its therapeutic versatility and its potential for harm. This complexity demands nuanced approaches to both research and clinical use.

Questions still open

  • Can specific neurotransmitter interactions be targeted to maximize therapeutic effects? Does the serotonin interaction explain CBD anxiolytic effects? How do different cannabinoid ratios preferentially affect different systems?

Common questions

Why does cannabis affect so many things?
Cannabinoid receptors modulate six major neurotransmitter systems in the brain: dopamine, serotonin, noradrenaline, GABA, glutamate, and opioids. This explains effects ranging from pain relief to mood changes to psychosis risk.
Are acute and chronic effects different?
Yes. Acute and chronic cannabis exposure produce distinct changes in these neurotransmitter systems, which is why short-term effects often differ from long-term consequences.

Read the original research

Modulatory effects of cannabinoids on brain neurotransmission.

The European journal of neuroscience, 50(3), 2322-2345

Citation

Cohen, Koby; Weizman, Abraham; Weinstein, Aviv. (2019). Modulatory effects of cannabinoids on brain neurotransmission.. The European journal of neuroscience, 50(3), 2322-2345. https://doi.org/10.1111/ejn.14407

Explore the wider topic